SCHEMBL18239142

SCHEMBL18239142

c1ccc(-c2nc(-c3ccc4c(c3)c3ccccc3n3c5ccccc5c5c6ccccc6c6c7ccccc7n4c6c53)nc3ccccc23)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
ATM Q13315 1/20 0.49
NPY5R Q15761 1/20 0.41
WHR1 P49842 1/20 0.40
NUDT1 P36639 3/20 0.38
ADORA2A P29274 3/20 0.38
ALDH1A1 P00352 5/20 0.38
KDM4E B2RXH2 4/20 0.38
HPGD P15428 4/20 0.38
MAPT P10636 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.36
GAA P10253 1/20 0.36
LMNA P02545 1/20 0.36
PTGER4 P35408 2/20 0.35
POLB P06746 1/20 0.35
HSD17B10 Q99714 1/20 0.35
PDK1 Q15118 1/20 0.35
PTGES O14684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18239165 0.90 MEN1 (0.51) MEN1KMT2AATMNPY5RWHR1
SCHEMBL20200140 0.89 MEN1 (0.50) MEN1KMT2AATMNPY5RWHR1
SCHEMBL20444360 0.88 MEN1 (0.44) MEN1KMT2AATMNPY5RWHR1
SCHEMBL17704944 0.86 MEN1 (0.50) MEN1KMT2AATMNPY5RWHR1
SCHEMBL18239194 0.85 MEN1 (0.44) MEN1KMT2AATMNPY5RWHR1
SCHEMBL19725221 0.85 ATM (0.42) MEN1KMT2AATMNPY5RWHR1
SCHEMBL17704966 0.85 MEN1 (0.54) MEN1KMT2AATMWHR1NUDT1
SCHEMBL17704958 0.85 MEN1 (0.54) MEN1KMT2AATMWHR1NUDT1
SCHEMBL17704939 0.84 MEN1 (0.52) MEN1KMT2AATMWHR1NUDT1
SCHEMBL17704986 0.84 MEN1 (0.48) MEN1KMT2AATMNPY5RWHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180151809-A1 ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2018-05-31 US disclosed
US-20180151809-A1 ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2018-05-31 US disclosed
WO-2016182186-A1 ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2016-11-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180151809-A1 ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME ELAVL1, OPA1, MT-ND4 MEN1 1878/4885KMT2A 2359/4885ATM 3977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.